Kenneth Cusi, M.D., F.A.C.P., F.A.C.E, serves as Chief of the Division of Endocrinology, Diabetes and Metabolism in the College of Medicine at the University of Florida. In this role, he serves as a mentor for faculty and fellows in the division to help UF&Shands take the next step in becoming an international leader in adult diabetes, metabolism, and obesity.
Recently, Dr. Cusi was featured in Endocrine Today magazine to talk about the relationship between diabetes and nonalcoholic fatty liver disease (NAFLD); his area of research expertise. “Physicians need to be aware that obesity and diabetes are the two most common predisposing factors to fatty liver,” he said.
The article takes an in-depth look at the clinical diagnosis of both NAFLD and NASH (nonalcoholic steatohepatitis); exploring treatment options including nutritional supplements, diabetes-related drugs, and lifestyle changes, and discusses how the Affordable Care Act (ACA) will shape future research.
Continued research efforts will focus on catering the conditions to preventative medicine measures and specifically to pediatric and youth populations. “Many children and teens could already have elevated liver enzymes, which may lead to NAFLD or NASH, along with the possibility for decades of liver damage,” he said.